Literature DB >> 33067777

Uric Acid and Gluconic Acid as Predictors of Hyperglycemia and Cytotoxic Injury after Stroke.

Zsuzsanna Ament1,2, Matthew B Bevers3, Zoe Wolcott1,2, W Taylor Kimberly4,5, Animesh Acharjee6,7,8.   

Abstract

Hyperglycemia is a feature of worse brain injury after acute ischemic stroke, but the underlying metabolic changes and the link to cytotoxic brain injury are not fully understood. In this observational study, we applied regression and machine learning classification analyses to identify metabolites associated with hyperglycemia and a neuroimaging proxy for cytotoxic brain injury. Metabolomics and lipidomics were carried out using liquid chromatography-tandem mass spectrometry in admission plasma samples from 381 patients presenting with an acute stroke. Glucose was measured by a central clinical laboratory, and a subgroup of patients (n = 201) had apparent diffusion coefficient (ADC) imaging quantified on magnetic resonance imaging (MRI) to estimate cytotoxic injury. Uric acid was the leading metabolite in univariate analysis of both hyperglycemia (OR 19.6, 95% CI 8.6-44.7, P = 1.44 × 10-12) and ADC (OR 5.3, 95% CI 2.2-13.0, P = 2.42 × 10-4). To further prioritize model features and account for non-linear correlation structure, a random forest machine learning algorithm was applied to separately model hyperglycemia and ADC. The statistical techniques used have identified uric acid and gluconic acids as leading candidate markers common to all models (R2 = 68%, P = 2.2 × 10-10 for uric acid; R2 = 15%, P = 8.09 × 10-10 for gluconic acid). Both uric acid and gluconic acid were associated with hyperglycemia and cytotoxic brain injury. Both metabolites are linked to oxidative stress, which highlights two candidate targets for limiting brain injury after stroke.

Entities:  

Keywords:  Hyperglycemia; Machine learning; Metabolomics; Neuroimaging; Stroke

Mesh:

Substances:

Year:  2020        PMID: 33067777      PMCID: PMC7933067          DOI: 10.1007/s12975-020-00862-5

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  38 in total

1.  Relation of apparent diffusion coefficient changes and metabolic disturbances after 1 hour of focal cerebral ischemia and at different reperfusion phases in rats.

Authors:  L Olah; S Wecker; M Hoehn
Journal:  J Cereb Blood Flow Metab       Date:  2001-04       Impact factor: 6.200

2.  Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke.

Authors:  J F Scott; G M Robinson; J M French; J E O'Connell; K G Alberti; C S Gray
Journal:  Lancet       Date:  1999-01-30       Impact factor: 79.321

3.  Hyperglycemia predicts poststroke infections in acute ischemic stroke.

Authors:  Thomas P Zonneveld; Paul J Nederkoorn; Willeke F Westendorp; Matthijs C Brouwer; Diederik van de Beek; Nyika D Kruyt
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

4.  Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion.

Authors:  P K Yip; Y Y He; C Y Hsu; N Garg; P Marangos; E L Hogan
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 5.  Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management.

Authors:  Nyika D Kruyt; Geert Jan Biessels; J Hans Devries; Yvo B Roos
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

6.  Chronic hyperglycemia is related to poor functional outcome after acute ischemic stroke.

Authors:  Merel Ja Luitse; Birgitta K Velthuis; L Jaap Kappelle; Yolanda van der Graaf; Geert Jan Biessels
Journal:  Int J Stroke       Date:  2016-10-26       Impact factor: 5.266

7.  Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances.

Authors:  M Hoehn-Berlage; D G Norris; K Kohno; G Mies; D Leibfritz; K A Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  1995-11       Impact factor: 6.200

8.  Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites.

Authors:  T Back; M Hoehn-Berlage; K Kohno; K A Hossmann
Journal:  Stroke       Date:  1994-02       Impact factor: 7.914

9.  Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke.

Authors:  L S Williams; J Rotich; R Qi; N Fineberg; A Espay; A Bruno; S E Fineberg; W R Tierney
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

10.  Hyperglycemia accelerates apparent diffusion coefficient-defined lesion growth after focal cerebral ischemia in rats with and without features of metabolic syndrome.

Authors:  David Tarr; Delyth Graham; Lisa A Roy; William M Holmes; Christopher McCabe; I Mhairi Macrae; Keith W Muir; Deborah Dewar
Journal:  J Cereb Blood Flow Metab       Date:  2013-07-10       Impact factor: 6.200

View more
  7 in total

1.  Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide.

Authors:  Hannah J Irvine; Animesh Acharjee; Zoe Wolcott; Zsuzsanna Ament; H E Hinson; Bradley J Molyneaux; J Marc Simard; Kevin N Sheth; W Taylor Kimberly
Journal:  Cell Rep Med       Date:  2022-06-13

2.  Nucleosides Associated With Incident Ischemic Stroke in the REGARDS and JHS Cohorts.

Authors:  Zsuzsanna Ament; Amit Patki; Ninad Chaudhary; Varun M Bhave; Ana-Lucia Garcia Guarniz; Yan Gao; Robert E Gerszten; Adolfo Correa; Suzanne E Judd; Mary Cushman; D Leann Long; M Ryan Irvin; W Taylor Kimberly
Journal:  Neurology       Date:  2022-03-09       Impact factor: 11.800

3.  Delayed rFGF21 Administration Improves Cerebrovascular Remodeling and White Matter Repair After Focal Stroke in Diabetic Mice.

Authors:  Yinghua Jiang; Jinrui Han; Yadan Li; Yinga Wu; Ning Liu; Samuel X Shi; Li Lin; Jing Yuan; Shusheng Wang; Ming-Ming Ning; Aaron S Dumont; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2021-09-15       Impact factor: 6.829

4.  Integrated transcriptomics and metabolomics analysis of the hippocampus reveals altered neuroinflammation, downregulated metabolism and synapse in sepsis-associated encephalopathy.

Authors:  Kejia Xu; Hui Li; Bing Zhang; Meini Le; Qiong Huang; Rao Fu; Giorgia Croppi; Gang Qian; Junjie Zhang; Guangming Zhang; Yinzhong Lu
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

5.  Influence of Optimal Management of Hyperglycemia and Intensive Nursing on Blood Glucose Control Level and Complications in Patients with Postoperative Cerebral Hemorrhage.

Authors:  Dandan Sun; Liang Sun; Fang Su
Journal:  Comput Math Methods Med       Date:  2022-08-29       Impact factor: 2.809

6.  Long-Term Effects of Repeated Blast Exposure in United States Special Operations Forces Personnel: A Pilot Study Protocol.

Authors:  Brian L Edlow; Yelena G Bodien; Timothy Baxter; Heather G Belanger; Ryan J Cali; Katryna B Deary; Bruce Fischl; Andrea S Foulkes; Natalie Gilmore; Douglas N Greve; Jacob M Hooker; Susie Y Huang; Jessica N Kelemen; W Taylor Kimberly; Chiara Maffei; Maryam Masood; Daniel P Perl; Jonathan R Polimeni; Bruce R Rosen; Samantha L Tromly; Chieh-En J Tseng; Eveline F Yao; Nicole R Zürcher; Christine L Mac Donald; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2022-06-29       Impact factor: 4.869

7.  Uric Acid and Clinical Outcomes in Young Patients with Ischemic Stroke.

Authors:  Yanfang Liu; Xinmin Liu; Jiaokun Jia; Jiahuan Guo; Guangshuo Li; Xingquan Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-29       Impact factor: 2.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.